In Brief This Week: Thermo Fisher Scientific; Agilent; Shuwen Biotech; and More | GenomeWeb

NEW YORK (GenomeWeb) – Thermo Fisher Scientific announced this week that it has completed its $4.2 billion acquisition of electron microscopy company FEI. Thermo Fisher paid $107.50 per share in cash. FEI will become part of Thermo Fisher's analytical instruments business unit.


Agilent Technologies said this week that its board has approved a quarterly dividend of $.12 per share of common stock, to be paid on Oct. 26, to all shareholders of record as of Oct. 4.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.